Related Experiment Video
Updated: Feb 5, 2026

Activating Autophagy by Aerobic Exercise in Mice
Published on: February 3, 2017
Mir223 restrains autophagy and promotes CNS inflammation by targeting ATG16L1
Yan Li1, Dongmei Zhou1, Yinghui Ren2
1a Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Hormones and Development (Ministry of Health) , Tianjin Medical University , Tianjin , China.
Abstract:
Microglia are innate immune cells in the central nervous system (CNS), that supplies neurons with key factors for executing autophagosomal/lysosomal functions. Macroautophagy/autophagy is a cellular catabolic process that maintains cell balance in response to stress-related stimulation. Abnormal autophagy occurs with many pathologies, such as cancer, and autoimmune and neurodegenerative diseases. Hence, clarification of the mechanisms of autophagy regulation is of utmost importance. Recently, researchers presented microRNAs (miRNAs) as novel and potent modulators of autophagic activity. Here, we found that Mir223 deficiency significantly ameliorated CNS inflammation, demyelination and the clinical symptoms of experimental autoimmune encephalomyelitis (EAE) and increased resting microglia and autophagy in brain microglial cells. In contrast, the autophagy inhibitor 3-methylademine (3-MA) aggravated the clinical symptoms of EAE in wild-type (WT) and Mir223-deficienct mice. Furthermore, it was confirmed that Mir223 deficiency in mice increased the protein expression of ATG16L1 (autophagy related 16-like 1 [S. cerevisiae]) and LC3-II in bone marrow-derived macrophage cells compared with cells from WT mice. Indeed, the cellular level of Atg16l1 was decreased in BV2 cells upon Mir223 overexpression and increased following the introduction of antagomirs. We also showed that the 3' UTR of Atg16l1 contained functional Mir223-responsive sequences and that overexpression of ATG16L1 returned autophagy to normal levels even in the presence of Mir223 mimics. Collectively, these data indicate that Mir223 is a novel and important regulator of autophagy and that Atg16l1 is a Mir223 target in this process, which may have implications for improving our understanding of the neuroinflammatory process of EAE. Abbreviations: 3-MA: 3-methylademine; ACTB/β-actin: actin, beta; ATG: autophagy related; ATG16L1: autophagy related 16-like 1 (S. cerevisiae); BECN1: beclin 1, autophagy related; CNR2: cannabinoid receptor 2 (macrophage); CNS: central nervous system; CQ: chloroquine; EAE: experimental autoimmune encephalomyelitis; FOXO3: forkhead box O3; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; H&E: hematoxylin and eosin; ITGAM: integrin alpha M; LPS: lipoplysaccharide; MAP1LC3/LC3: microtubule-associated protein 1 light chain 3; miRNAs: microRNAs; MS: multiple sclerosis; PPARG: peroxisome proliferator activated receptor gamma; PTPRC: protein tyrosine phosphatase, receptor type, C; RA: rheumatoid arthritis; SQSTM1: sequestosome 1; TB: tuberculosis; TIMM23: translocase of inner mitochondrial membrane 23; TLR: toll-like receptor.
Insights
MicroRNA-223 (Mir223) deficiency ameliorates neuroinflammation in experimental autoimmune encephalomyelitis (EAE) by enhancing autophagy. Autophagy regulation via Mir223 and its target ATG16L1 offers potential therapeutic strategies for EAE.
Area of Science:
- Neuroimmunology
- Cellular Biology
- Molecular Medicine
Background:
- Microglia are central nervous system immune cells crucial for neuronal health.
- Autophagy, a cellular degradation process, is vital for maintaining cellular homeostasis and implicated in various diseases.
- MicroRNAs (miRNAs) are emerging regulators of autophagy, making their role in neuroinflammation a key research area.
Purpose of the Study:
- To investigate the role of microRNA-223 (Mir223) in regulating autophagy in microglia.
- To elucidate the impact of Mir223 on experimental autoimmune encephalomyelitis (EAE), a model of neuroinflammation.
- To identify downstream targets of Mir223 involved in autophagy modulation.
Main Methods:
- Utilized a mouse model of EAE with and without Mir223.
- Administered autophagy inhibitor 3-methyladenine (3-MA) to assess its effects on EAE severity.
- Analyzed protein expression of autophagy-related genes (ATG16L1, LC3-II) in microglia and bone marrow-derived macrophages.
- Performed luciferase reporter assays to confirm direct targeting of ATG16L1 by Mir223.
Main Results:
- Mir223 deficiency significantly reduced CNS inflammation, demyelination, and clinical symptoms in EAE.
- Mir223 deficiency led to increased autophagy and resting microglia in the brain.
- Inhibition of autophagy aggravated EAE symptoms, irrespective of Mir223 status.
- Mir223 directly targets ATG16L1, a key autophagy-related gene, and its modulation impacts autophagic activity.
Conclusions:
- Mir223 acts as a negative regulator of autophagy in microglia.
- Mir223 deficiency ameliorates EAE by enhancing autophagy, with ATG16L1 identified as a direct target.
- Targeting the Mir223-ATG16L1 axis represents a potential therapeutic strategy for neuroinflammatory diseases like EAE.
More Related Videos
Related Concept Videos
Inflammation
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
CNS Depressants: Alcohol and Nicotine
CNS Depressants: Barbiturates and Benzodiazepines

